Trial Information

Summary: A study to evaluate the tolerability of a study drug to help people with B-cell lymphocytic leukemia (B-CLL)

Summary:

Genitope Corp. is currently recruiting subjects with B-cell lymphocytic leukemia (B-CLL, cancer of the white blood cells) to participate in an experimental study.

Study drug and study procedures will be made available to you at no cost.

To qualify, you must:

  • Be 18years of age or older
  • Be diagnosed with B-CLL
  • Have had no prior therapy for you B-CLL

You will not qualify, if you:

  • Have had a prior malignancy without being disease free for at least 5 years
  • Have known HIV, Hepatitis B or Hepatitis C
  • Are pregnant or breastfeeding
  • Are participating in another clinical study

Research being conducted at:

Contact:

Peter Garofalo, Research Coordinator
Biomedical Research Alliance of New York
Long Island Jewish Medical Center
270-05 76th Avenue
New Hyde Park, NY 11040
Telephone: 718-470-7135
Email:

Profile Page: Biomedical Research Alliance of New York, New Hyde Park, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:52 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA